At Sciensus Rare we believe in making sure every family has access to rare disease medicines and care or support they need. So, no matter where a patient lives or the regulatory governance of that country, we can safely launch and efficiently deliver vital medication and services for families that need it most.
As your partner, we provide a patient tailored end-to-end service that underpins and supports accelerated growth. As clinical experts, we improve patient adherence and persistence while ensuring patient safety at all times.
Delivering patient-centric solutions to the most convenient place to help facilitate the best outcome for patients and families.
Sciensus Rare has supported In excess of 200,000 patients across the UK and Europe,with over 90,000 clinical deliveries direct to patients and over 1000 deliveries (single and bulk) to hospitals, wholesalers and pharmacies across 22 countries every month We have a clinically focused workforce: approx. 50% of which are clinically qualified.
Fully licensed both in NL,UK holding relevant EMA, GDP and MHRA licenses, with each hub having its own GDP responsible person Sciensus has a co-ordinated global approach to corporate governance, by centralising all regulatory leads into a single team – chief clinical officer, responsible person and chief pharmacist – we can align operational delivery with regulatory, legal and contractual commitments.
If you wish to discuss your requirements in relation to any of our services do not hesitate to contact either Robert Clements at Robert.clements@sciensus.com or Andrew Cummins at Andrew.cummins@sciensus.com
